Author Frölich, Lutz
-
2024 | Book Chapter
Blood-Based Biomarkers for Early Alzheimer’s Disease Diagnosis in Real-World Settings
Perneczky, R.; Hansen, N.; Hofmann, A.; Laske, C.; Priller, J.; Grimmer, T.& Frölich, L. et al. (2024)
In:Perneczky, Robert (Ed.), Biomarkers for Alzheimer’s Disease Drug Development pp. 3-14. New York, NY: Springer US. DOI: https://doi.org/10.1007/978-1-0716-3774-6_1
Details DOI
-
2023 | Journal Article
Apathy in patients with Alzheimer's disease is a cost‐driving factor
Kruse, C.; Maier, F.; Spottke, A.; Bach, J.; Bartels, C.; Buerger, K. & Fellgiebel, A. et al. (2023)
Alzheimer's & Dementia, art. alz.12915. DOI: https://doi.org/10.1002/alz.12915
Details DOI
-
2022 | Journal Article
Kosten der Diagnostik kognitiver Störungen in deutschen Gedächtnisambulanzen
Onur, O. A.; Wolff-Menzler, C. ; Arnim, C. A. F. von ; Jessen, F.; Fink, G. R.; Wiltfang, J. & Laske, C. et al. (2022)
Fortschritte der Neurologie · Psychiatrie, 90(07/08) pp. 361-367. DOI: https://doi.org/10.1055/a-1871-9889
Details DOI
-
2022 | Journal Article
Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
Frölich, L.; Arnim, C. von ; Bohlken, J.; Pantel, J.; Peters, O. & Förstl, H. (2022)
Zeitschrift für Gerontologie und Geriatrie,. DOI: https://doi.org/10.1007/s00391-022-02098-4
Details DOI
-
2022 | Journal Article |
Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network
Benson, G. S.; Bauer, C.; Hausner, L.; Couturier, S.; Lewczuk, P.; Peters, O. & Hüll, M. et al. (2022)
Journal of Neural Transmission,. DOI: https://doi.org/10.1007/s00702-022-02461-0
Details DOI
-
2022 | Journal Article |
A Comparison of Operational Definitions for Mild Cognitive Impairment
Polcher, A.; Wolfsgruber, S.; Peters, O.; Frölich, L.; Wiltfang, J. ; Kornhuber, J. & Hüll, M. et al. (2022)
Journal of Alzheimer's Disease, 88(4) pp. 1663-1678. DOI: https://doi.org/10.3233/JAD-215548
Details DOI
-
2022 | Journal Article | Erratum |
Erratum zu: Leichte kognitive Beeinträchtigung (MCI) in der altersmedizinischen Praxis: Patientenorientierung, Diagnostik, Behandlung und Ethik
Frölich, L.; Arnim, C. A. F. von ; Bohlken, J.; Pantel, J.; Peters, O. & Förstl, H. (2022)
Zeitschrift für Gerontologie und Geriatrie,. DOI: https://doi.org/10.1007/s00391-022-02114-7
Details DOI
-
2021 | Journal Article
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments
Ophey, A.; Wolfsgruber, S.; Roeske, S.; Polcher, A.; Spottke, A.; Frölich, L. & Hüll, M. et al. (2021)
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 13(1). DOI: https://doi.org/10.1002/dad2.12223
Details DOI
-
2020 | Journal Article
Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis
Fuentes, M.; Klostermann, A.; Kleineidam, L.; Bauer, C.; Schuchhardt, J.; Maier, W. & Jessen, F. et al. (2020)
Journal of Alzheimer's Disease, 76(3) pp. 1005-1015. DOI: https://doi.org/10.3233/JAD-200230
Details DOI
-
2020 | Journal Article
Bupropion for the Treatment of Apathy in Alzheimer Disease
Maier, F.; Spottke, A.; Bach, J.-P.; Bartels, C. ; Buerger, K.; Dodel, R. & Fellgiebel, A. et al. (2020)
JAMA Network Open, 3(5) pp. e206027. DOI: https://doi.org/10.1001/jamanetworkopen.2020.6027
Details DOI
-
2020 | Journal Article
Association of a CAMK2A genetic variant with logical memory performance and hippocampal volume in the elderly
Rhein, C.; Mühle, C.; Lenz, B.; Richter-Schmidinger, T.; Kogias, G.; Boix, F. & Lourdusamy, A. et al. (2020)
Brain Research Bulletin, 161 pp. 13-20. DOI: https://doi.org/10.1016/j.brainresbull.2020.05.001
Details DOI
-
2020 | Journal Article |
Gedächtnisambulanzen in Deutschland – strukturell-organisatorische Voraussetzungen und Aufgabenfelder
Hausner, L.; Frölich, L.; von Arnim, C. A. F. ; Bohlken, J.; Dodel, R.; Otto, M. & Rapp, M. et al. (2020)
Der Nervenarzt,. DOI: https://doi.org/10.1007/s00115-020-01007-7
Details DOI
-
2020 | Journal Article |
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment
Kleineidam, L.; Chouraki, V.; Próchnicki, T.; van der Lee, S. J.; Madrid-Márquez, L.; Wagner-Thelen, H. & Karaca, I. et al. (2020)
Acta Neuropathologica, 139(6) pp. 1025-1044. DOI: https://doi.org/10.1007/s00401-020-02138-6
Details DOI
-
2019 | Journal Article
P3-016: Bupropion for the Treatment of Apathy in Alzheimer's Disease: a Multicenter Randomized Controlled Trial
Jessen, F.; Maier, F.; Buerger, K.; Dodel, R.; Fellgiebel, A.; Frölich, L. & Horn, R. et al. (2019)
Alzheimer's & Dementia, 15 pp. P930-P931. DOI: https://doi.org/10.1016/j.jalz.2019.06.3042
Details DOI
-
2019 | Journal Article |
A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2
Karsak, M.; Glebov, K.; Scheffold, M.; Bajaj, T.; Kawalia, A.; Karaca, I. & Rading, S. et al. (2019)
Human Mutation, 41(1) pp. 1-13. DOI: https://doi.org/10.1002/humu.23904
Details DOI
-
2018 | Journal Article
Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
Espinosa, A.; Hernández-Olasagarre, B.; Moreno-Grau, S.; Kleineidam, L.; Heilmann-Heimbach, S.; Hernández, I. & Wolfsgruber, S. et al. (2018)
Frontiers in Aging Neuroscience, 10. DOI: https://doi.org/10.3389/fnagi.2018.00340
Details DOI
-
2017 | Journal Article
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
Bos, I.; Vos, S. J.; Frölich, L.; Kornhuber, J. ; Wiltfang, J. ; Maier, W. & Peters, O. et al. (2017)
Neurobiology of Aging, 56 pp. 33-40. DOI: https://doi.org/10.1016/j.neurobiolaging.2017.03.034
Details DOI
-
2017 | Journal Article |
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
Frölich, L.; Peters, O.; Lewczuk, P. ; Gruber, O. ; Teipel, S. J.; Gertz, H. J. & Jahn, H. et al. (2017)
Alzheimer's Research & Therapy, 9(1) art. 84. DOI: https://doi.org/10.1186/s13195-017-0301-7
Details DOI
-
2017 | Journal Article
Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment
Wolfsgruber, S.; Polcher, A.; Koppara, A.; Kleineidam, L.; Frölich, L.; Peters, O. & Hüll, M. et al. (2017)
Journal of Alzheimer's Disease, 58(3) pp. 939-950. DOI: https://doi.org/10.3233/JAD-161252
Details DOI PMID PMC WoS
-
2016 | Journal Article
No association of the variant rs11887120 in DNMT3A with cognitive decline in individuals with mild cognitive impairment
Bey, K.; Wolfsgruber, S.; Karaca, I.; Wagner, H.; Lardenoije, R.; Becker, J. & Milz, E. et al. (2016)
Epigenomics, 8(5) pp. 593-598. DOI: https://doi.org/10.2217/epi-2015-0014
Details DOI